Post-COVID Interstitial Lung Disease-The Tip of the Iceberg

Namrata Kewalramani1, Kerri-Marie Heenan2, Denise McKeegan2

  • 1Department for BioMedical Research DBMR, Inselspital, Bern University Hospital, University of Bern, Switzerland; Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Insights

Long COVID, a significant health burden, involves persistent symptoms after COVID-19 infection. This review examines emerging evidence on post-COVID interstitial lung disease, its mechanisms, and impact.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Pathophysiology

Background:

  • Post-COVID condition (long COVID) presents a substantial burden on patients and healthcare systems.
  • Understanding the long-term effects of COVID-19 is crucial for effective patient management.
  • Emerging respiratory complications require focused investigation.

Purpose of the Study:

  • To review the current evidence on the development of post-COVID interstitial lung disease.
  • To explore the pathophysiological mechanisms, incidence, and diagnostic approaches.
  • To assess the impact of this emerging respiratory condition.

Main Methods:

  • Systematic literature review of emerging evidence.
  • Analysis of pathophysiological mechanisms.
  • Evaluation of diagnostic criteria and incidence data.

Main Results:

  • Growing evidence suggests interstitial lung disease as a sequela of COVID-19.
  • Specific pathophysiological pathways are being identified.
  • Incidence and long-term impact data are still developing.

Conclusions:

  • Post-COVID interstitial lung disease is an emerging concern requiring further research.
  • Understanding its development is key to managing long-term respiratory health after COVID-19.
  • Early diagnosis and intervention strategies are needed.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
385
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K